Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Ashraf I Reyad, Ann Dao, Jacfranz J Guiteau, Machaiah M Madhrira, Sridhar R Allam
This case describes successful renal transplantation in an elderly patient following diagnosis with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. Forty-six days prior to transplant, a 65-year-old African American Male with end stage renal disease on kidney transplant waitlist, hypertension, hyperlipidemia, and chronic diastolic heart failure presented to the emergency department and was diagnosed with SARS-CoV-2 pneumonia. Following treatment with dexamethasone and convalescent plasma therapy during the two-week inpatient admission, the patient was discharged home. Subsequently, the patient was reactivated on waitlist following two confirmatory negative SARS-CoV-2 PCR tests. Upon the transplant admission, repeat PCR and rapid antigen tests resulted negative. The patient received anti-thymocyte globulin 4.5 mg/kg as induction therapy. Post-operative course was uneventful with immediate graft function. Maintenance therapy included tacrolimus, mycophenolate, and corticosteroid taper. A SARS-CoV-2 IgG antibody test collected during the admission resulted positive. The patient was discharged on post-operative day 4 with a serum creatinine of 1.6 mg/dL. At 2 month following transplant, the patient remains asymptomatic with stable renal function. In this case report, the patient safely received T-cell depleting induction therapy following SAR-CoV-2 pneumonia. Positive SARS-CoV-2 antibodies at the time of transplant may have provided protection against recurrent infection.